SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER Drug Patent Profile
✉ Email this page to a colleague
When do Sodium Chloride 0.9% In Plastic Container patents expire, and what generic alternatives are available?
Sodium Chloride 0.9% In Plastic Container is a drug marketed by B Braun, Fresenius Kabi Usa, Fresenius Medcl, Haemonetics, Hospira, Icu Medical Inc, Laboratorios Grifols, Liebel-flarsheim, Abbott, Baxter Hlthcare, Jubilant Cadista, Miles, Nephron, and Taro. and is included in twenty-six NDAs.
The generic ingredient in SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER is sodium chloride. There are one thousand four hundred and seventy-two drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the sodium chloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER?
- What are the global sales for SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER?
- What is Average Wholesale Price for SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER?
Summary for SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
US Patents: | 0 |
Applicants: | 14 |
NDAs: | 26 |
Finished Product Suppliers / Packagers: | 20 |
Raw Ingredient (Bulk) Api Vendors: | 126 |
Formulation / Manufacturing: | see details |
DailyMed Link: | SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER at DailyMed |
![SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER drug patent expirations Drug patent expirations by year for SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER](/p/graph/s/t/SODIUM_CHLORIDE_0.9%_IN_PLASTIC_CONTAINER-patent-expirations.png)
Pharmacology for SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
Drug Class | Osmotic Laxative |
Mechanism of Action | Osmotic Activity |
Physiological Effect | Increased Large Intestinal Motility Inhibition Large Intestine Fluid/Electrolyte Absorption |